We treated 2 patients with ABCG5 mutations and sitosterolemia with ezetimibe to reduce cholesterol and plant sterol absorption, leading to the normalization of thrombocytopenia, peripheral smear findings, and hemolytic anemia. This evidence concerns the gene ABCG5 and Thrombocytopenia.